Ultima Genomics
PrivateLast Round
Early Funding
May 31, 2022
Total Funding Raised
$604.45M
Company Overview
Ultima Genomics is a biotechnology company that develops and manufactures high-throughput, low-cost genome sequencing platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ultima Genomics Comparables
Compare Ultima Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Element Biosciences | 88% | |
| MGI | 78% | |
| GeneMind Biosciences Co., Ltd. | 77% |
Ultima Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 31, 2022 | ||||
| Grant | Apr 1, 2021 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
OFFER |
Key People
Founding team and executive leadership
Ultima Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Early Funding |
| Khosla Ventures | Early Funding, Seed |
| NIH RADx | Grant |
| Playground Global | Early Funding |
| Founders Fund | Early Funding |
| D1 Capital Partners | Early Funding |
| aMoon | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2026
Launched the UG200 Series, a next-generation sequencing platform.
- Feb 25, 2026
Presented technologies at the AGBT Conference on February 25, 2026.
Ultima Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ultima Genomics's valuation, stock price, and market status.
Is Ultima Genomics a public or private company?
Ultima Genomics is a private company.
What is the current stock price of Ultima Genomics?
Ultima Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Ultima Genomics worth (valuation)?
Valuation information for Ultima Genomics is not publicly available.
Can I buy Ultima Genomics stock?
Ultima Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ultima Genomics's last funding round?
Ultima Genomics's most recent funding round was Early Funding on May 31, 2022.
Who are the main investors in Ultima Genomics?
Key investors in Ultima Genomics include Andreessen Horowitz, Khosla Ventures, NIH RADx, Playground Global, Founders Fund.
Will Ultima Genomics IPO soon?
No public IPO plans have been announced for Ultima Genomics.
How can I track Ultima Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ultima Genomics's secondary market activity and sign up for updates.